BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28011473)

  • 1. Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models.
    Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Fujiwara T; Bouvet M; Hoffman RM
    Anticancer Res; 2017 Jan; 37(1):57-60. PubMed ID: 28011473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.
    Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Anticancer Res; 2016 Dec; 36(12):6273-6277. PubMed ID: 27919946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Metastatic Recurrence Via Lymphatic Trafficking of a High-Metastatic Variant of Human Triple-Negative Breast Cancer After Surgical Resection in Orthotopic Nude Mouse Models.
    Yano S; Takehara K; Tazawa H; Kishimoto H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    J Cell Biochem; 2017 Mar; 118(3):559-569. PubMed ID: 27626220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Isolation of a Highly-aggressive Variant of Triple-negative Human Breast Cancer MDA-MB-231 Using Serial Orthotopic Transplantation.
    Yano S; Takehara K; Miwa S; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Anticancer Res; 2016 Aug; 36(8):3817-20. PubMed ID: 27466482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeting adenovirus OBP-401 inhibits primary and metastatic tumor growth of triple-negative breast cancer in orthotopic nude-mouse models.
    Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Oncotarget; 2016 Dec; 7(51):85273-85282. PubMed ID: 27863373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro.
    Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Cancer Gene Ther; 2017 Feb; 24(2):45-47. PubMed ID: 28106046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a bioluminescent MDA-MB-231 cell line for human triple-negative breast cancer research.
    Wang K; Xie S; Ren Y; Xia H; Zhang X; He J
    Oncol Rep; 2012 Jun; 27(6):1981-9. PubMed ID: 22446691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft].
    Wang K; Xie SM; He JJ; Ren Y; Xia HB; Zhang XW
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1812-8. PubMed ID: 22126756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF13 promotes metastasis of triple-negative breast cancer.
    Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH
    Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocan as a prognostic biomarker of triple-negative breast cancer.
    Sagara A; Igarashi K; Otsuka M; Kodama A; Yamashita M; Sugiura R; Karasawa T; Arakawa K; Narita M; Kuzumaki N; Narita M; Kato Y
    Breast Cancer Res Treat; 2017 Jan; 161(2):269-278. PubMed ID: 27888420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
    Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
    Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
    Fricke IB; De Souza R; Costa Ayub L; Francia G; Kerbel R; Jaffray DA; Zheng J
    PLoS One; 2018; 13(5):e0196892. PubMed ID: 29723251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancer.
    Kong B; Lv ZD; Wang Y; Jin LY; Ding L; Yang ZC
    Int J Clin Exp Pathol; 2015; 8(9):11076-83. PubMed ID: 26617826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-(4-Hydroxy-3-methoxyphenyl)-benzothiazole suppresses tumor progression and metastatic potential of breast cancer cells by inducing ubiquitin ligase CHIP.
    Hiyoshi H; Goto N; Tsuchiya M; Iida K; Nakajima Y; Hirata N; Kanda Y; Nagasawa K; Yanagisawa J
    Sci Rep; 2014 Nov; 4():7095. PubMed ID: 25403352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant treatment with tumor-targeting Salmonella typhimurium A1-R reduces recurrence and increases survival after liver metastasis resection in an orthotopic nude mouse model.
    Murakami T; Hiroshima Y; Zhao M; Zhang Y; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    Oncotarget; 2015 Dec; 6(39):41856-62. PubMed ID: 26497690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.
    Maawy AA; Hiroshima Y; Zhang Y; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
    J Surg Res; 2015 Jul; 197(1):5-11. PubMed ID: 25799527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125.
    Seitz S; Buchholz S; Schally AV; Weber F; Klinkhammer-Schalke M; Inwald EC; Perez R; Rick FG; Szalontay L; Hohla F; Segerer S; Kwok CW; Ortmann O; Engel JB
    BMC Cancer; 2014 Nov; 14():847. PubMed ID: 25410881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.
    Zhu Y; Tao Z; Chen Y; Lin S; Zhu M; Ji W; Liu X; Li T; Hu X
    Breast Cancer Res Treat; 2022 May; 193(1):65-81. PubMed ID: 35254603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.